Numinus Wellness

Numinus Wellness is a publicly traded Canadian company operating one of the largest psychedelic therapy clinical research and services networks in North America. With clinics in Vancouver and Montreal, Numinus provides ketamine-assisted therapy and psilocybin-assisted therapy under Canada's Special Access Program, which allows licensed practitioners to use psilocybin with patients who have exhausted other treatment options. Numinus also conducts research and has trained hundreds of psychedelic therapy practitioners through their training programs.